Marca Suchard News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Researchers have developed a tool to personalize the consideration for pursuing intensive versus standard blood pressure treatment goals.

Jim Moore and I were both students in the PhD Program in Anthropology at Harvard a few years ago. He graduated about the time I entered the program. To give a rough historical touchstone, I remember the day he needed to get his thesis off to the Registrar, and there was a delay because it was taking longer than expected to deburst the pages fresh out of the printer.

Common high blood pressure drugs do not increase COVID-19 risk Credit: CC0 Public Domain While the COVID-19 pandemic left the world searching for answers, one healthcare concern is about the use of certain high blood pressure drugs, and whether the drugs posed increased COVID-19 risks. In a new study, researchers found that there was no increased risk of COVID-19 diagnosis, hospitalization, or complications for users of either angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) to treat high blood pressure. They tested more than 1.1 million patients who use ...

 E-Mail NEW YORK, NY (Dec. 17, 2020)--While the COVID-19 pandemic left the world searching for answers during the earliest stages of the pandemic, one immediate healthcare concern regarded the use of certain antihypertensives--and whether they posed increased risks to patients with hypertension. A new study by global collaborators within the Observational Health Data Sciences and Informatics (OHDSI) community found that there was no increased risk of COVID-19 diagnosis, hospitalization, or subsequent complications for users of either angiotensin-converting enzyme (ACE) inhibitors or angioten...